Lv3
241 积分 2020-11-03 加入
Discovery of a Potent, Selective, and Orally Efficacious STAT6 PROTAC for the Treatment of Atopic Dermatitis
8天前
已完结
Discovery of CRBN E3 Ligase Modulator CC-92480 for the Treatment of Relapsed and Refractory Multiple Myeloma
8天前
已完结
Ifebemtinib plus garsorasib in previously treated metastatic colorectal cancer with KRASG12C mutation: a multicentre, randomised, phase 1b/2 trial
15天前
已完结
Discovery of (3 R ,4 R )-15: An Advanced Factor B Inhibitor Entering Phase 3 for Complement-Mediated Diseases
23天前
已完结
Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer
1个月前
已完结
An updated patent review of STAT6 inhibitors and modulators (2020 – present)
1个月前
已完结
An updated patent review of STAT6 inhibitors and modulators (2020 – present)
1个月前
已完结
Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy
2个月前
已完结
HRA00129-C004, a Novel c-Met Antibody–Drug Conjugate, Exerts Encouraging Antitumor Activities and Favorable Safety Profiles
2个月前
已完结
Has Colorectal Cancer (c-)Met Its Match With Telisotuzumab Adizutecan?
2个月前
已完结
皖公网安备34019202002308
